ARCT Arcturus Therapeutics Holdings
$11.23▲ +13.32%
Healthcare
Other
After hours
$11.01▼ -1.96%
Oct 27, 5:00 PM ET
Volume 926.7K
Avg Volume (10D) 576.6K
Key Metrics & Fundamentals
Market Cap
$319.19M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.50 - 17.96
% vs 50 MA
-16.79%
% vs 200 MA
25.63%
RSI-14
45.3
MACD Histogram
-0.1400
Beta (1Y vs SPY)
1.95
Free Cash Flow
-$19.91M
Gross Rev
$880,000
Gross Profit
$880,000
EBITDA
-$24.84M
COGS
–
Operating Exp
$26.43M
Operating Income
-$25.55M
EBIT
-$25.55M
Pretax Income
-$23.79M
Net Income
-$23.79M
EPS (Diluted)
-0.84
Price & Volume History
Loading chart…
Recent News
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026
Business Wire · Oct 26, 2026 4:01 PM ET
Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Zacks · Oct 23, 2026 8:40 AM ET
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
Zacks · Sep 28, 2026 9:57 AM ET
Arcturus Highlights ARCT-810 Phase II Data, Unveils Next-Gen OTC Therapy Platform
MarketBeat · Sep 24, 2026 11:02 PM ET
CoreWeave upgraded, Etsy downgraded: Wall Street's top analyst calls
The Fly · Sep 24, 2026 9:41 AM ET
Citigroup Upgrades Arcturus Therapeutics to Buy From Neutral, Adjusts PT to $20 From $8
MT Newswires · Sep 24, 2026 6:35 AM ET
Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform
Business Wire · Sep 23, 2026 4:01 PM ET
Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform
Business Wire · Sep 18, 2026 9:00 AM ET
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
Business Wire · Aug 31, 2026 4:01 PM ET
Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?
Zacks · Aug 27, 2026 9:55 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARCT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.